Work

3:36 PM Abstract No. 265 Safety and feasibility of integrating yttrium-90 radioembolization with capecitabine-temozolomide for grade 2 liver-dominant metastatic neuroendocrine tumors (CapTemY90): final report

Year: 2018

Type: article

Source: Journal of Vascular and Interventional Radiology

DOI: 10.1016/j.jvir.2018.01.296

Authors: M. Soulen, U. Teitelbaum, D. van Houten, G. Deitrick, N. Damjanov, C. Gabriel, M. O’Hara, K. Cengel, J. Mondschein, M. Dagli, D. Metz

Institutions: University of Pennsylvania, Hospital of the University of Pennsylvania

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2789687047

FWCI:

Cites:

Cited by:

Related to: 10